[In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]

[In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]

Authors

  • Matteo Ferrario Direzione Market Access Roche SpA, Milano
  • Giovanni Giuliani Direzione Market Access Roche SpA, Milano

DOI:

https://doi.org/10.7175/fe.v18i1.1315

References

Regime di rimborsabilità e prezzo di vendita del medicinale per uso umano «Cotellic (cobimetinib)». Determina n. 1204/2016. GU n.230 del 1/10/2016

Classificazione del medicinale per uso umano «Mekinist» ai sensi dell’art. 8, comma 10,della legge 24 dicembre 1993, n. 537. Determina n. 1546/2016. GU n.2 del 3/1/2017

Regime di rimborsabilità e prezzo a seguito di nuove indicazioni terapeutiche del medicinale per uso umano «Tafinlar». Determina n. 1586/2016. GU n.5 del 7/1/2017

Downloads

Published

2017-09-12

How to Cite

Ferrario, M., & Giuliani, G. (2017). [In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]. Farmeconomia. Health Economics and Therapeutic Pathways, 18(1). https://doi.org/10.7175/fe.v18i1.1315

Issue

Vol. 18 No. 1 (2017)

Section

Letter to the Editor

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
  4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)

Most read articles by the same author(s)